Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Achillion Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

29 Apr 2016 Reuters Investment Profile 12 $20.00

ValuEngine Rating and Forecast Report for ACHN

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

01 May 2016 ValuEngine, Inc. 11 $25.00

Achillion Pharmaceuticals

30 Apr 2016 S&P Capital IQ Quantitative Report 10 $115.00

ACHILLION PHARMACEUTICALS INC (ACHN=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

30 Apr 2016 Pechala's Reports 2 $25.00

Thomson Reuters Stock Report - Achillion Pharmaceuticals Inc (ACHN-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

29 Apr 2016 Thomson Reuters Stock Report 12 $25.00

Wright Investors Service Comprehensive Report for Achillion Pharmaceuticals, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

29 Apr 2016 Wright Reports 55 $75.00

ACHN: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

29 Apr 2016 New Constructs, LLC 10 $25.00

Value Graph: ACHILLION PHARMA -- ACHN

29 Apr 2016 Ford Investor Services, Inc. 1 $12.00

Achillion Pharmaceuticals, Inc.

Achillion Pharmaceuticals, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The r...

25 Apr 2016 MarketLine 44 $50.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ACHILLION PHARMACEUTICALS including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

22 Apr 2016 Jefferson Research 11 $20.00